The Bioequivalence of Abexinostat (CRA‐024781) Tosylate Tablets (20 mg) in Chinese Healthy Subjects Under Fasting Conditions

Documenti analoghi

• Bioequivalence Study of Atenolol Tablets in Healthy Chinese Subjects Under Fasting and Fed Conditions
  di: Yongtao Li, et al.
  Pubblicazione: (2024)
• Bioequivalence Study of Two Olopatadine Hydrochloride Tablets in Chinese Healthy Subjects Under Fasting and Fed Conditions
  di: Yuyan Lei, et al.
  Pubblicazione: (2025)
• Comparative Pharmacokinetics and Bioequivalence of Two Sodium Valproate Tablets in Healthy Chinese Subjects Under Fasting and Fed Conditions
  di: Yuan Liu, et al.
  Pubblicazione: (2025)
• Bioequivalence Study of Bedaquiline Fumarate Tablets in Healthy Chinese Subjects
  di: Man Yang, et al.
  Pubblicazione: (2025)
• Bioequivalence and Food Effect Assessment Between 2 Oral Tablet Formulations of Rivaroxaban 20 mg in Healthy Chinese Subjects
  di: Kaixian Tang, et al.
  Pubblicazione: (2025)